Literature DB >> 22277121

Simple and rapid genetic testing for citrin deficiency by screening 11 prevalent mutations in SLC25A13.

Atsuo Kikuchi1, Natsuko Arai-Ichinoi, Osamu Sakamoto, Yoichi Matsubara, Takeyori Saheki, Keiko Kobayashi, Toshihro Ohura, Shigeo Kure.   

Abstract

Citrin deficiency is an autosomal recessive disorder caused by mutations in the SLC25A13 gene and has two disease outcomes: adult-onset type II citrullinemia and neonatal intrahepatic cholestasis caused by citrin deficiency. The clinical appearance of these diseases is variable, ranging from almost no symptoms to coma, brain edema, and severe liver failure. Genetic testing for SLC25A13 mutations is essential for the diagnosis of citrin deficiency because chemical diagnoses are prohibitively difficult. Eleven SLC25A13 mutations account for 95% of the mutant alleles in Japanese patients with citrin deficiency. Therefore, a simple test for these mutations is desirable. We established a 1-hour, closed-tube assay for the 11 SLC25A13 mutations using real-time PCR. Each mutation site was amplified by PCR followed by a melting-curve analysis with adjacent hybridization probes (HybProbe, Roche). The 11 prevalent mutations were detected in seven PCR reactions. Six reactions were used to detect a single mutation each, and one reaction was used to detect five mutations that are clustered in a 21-bp region in exon 17. To test the reliability, we used this method to genotype blind DNA samples from 50 patients with citrin deficiency. Our results were in complete agreement those obtained using previously established methods. Furthermore, the mutations could be detected without difficulty using dried blood samples collected on filter paper. Therefore, this assay could be used for newborn screening and for facilitating the genetic diagnosis of citrin deficiency, especially in East Asian populations. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277121     DOI: 10.1016/j.ymgme.2011.12.024

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  18 in total

1.  Screening of SLC25A13 mutation in the Thai population.

Authors:  Parith Wongkittichote; Chonlaphat Sukasem; Atsuo Kikuchi; Wichai Aekplakorn; Laran T Jensen; Shigeo Kure; Duangrurdee Wattanasirichaigoon
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

2.  Different regional distribution of SLC25A13 mutations in Chinese patients with neonatal intrahepatic cholestasis.

Authors:  Rui Chen; Xiao-Hong Wang; Hai-Yan Fu; Shao-Ren Zhang; Kuerbanjiang Abudouxikuer; Takeyori Saheki; Jian-She Wang
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

3.  mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency.

Authors:  Jingsong Cao; Ding An; Mikel Galduroz; Jenny Zhuo; Shi Liang; Marianne Eybye; Andrea Frassetto; Eishi Kuroda; Aki Funahashi; Jordan Santana; Cosmin Mihai; Kerry E Benenato; E Sathyajith Kumarasinghe; Staci Sabnis; Timothy Salerno; Kimberly Coughlan; Edward J Miracco; Becca Levy; Gilles Besin; Joshua Schultz; Christine Lukacs; Lin Guey; Patrick Finn; Tatsuhiko Furukawa; Paloma H Giangrande; Takeyori Saheki; Paolo G V Martini
Journal:  Mol Ther       Date:  2019-04-23       Impact factor: 11.454

4.  Functional characterization of tissue-specific enhancers in the DLX5/6 locus.

Authors:  Ramon Y Birnbaum; David B Everman; Karl K Murphy; Fiorella Gurrieri; Charles E Schwartz; Nadav Ahituv
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

5.  Deletions of exons with regulatory activity at the DYNC1I1 locus are associated with split-hand/split-foot malformation: array CGH screening of 134 unrelated families.

Authors:  Naeimeh Tayebi; Aleksander Jamsheer; Ricarda Flöttmann; Anna Sowinska-Seidler; Sandra C Doelken; Barbara Oehl-Jaschkowitz; Wiebke Hülsemann; Rolf Habenicht; Eva Klopocki; Stefan Mundlos; Malte Spielmann
Journal:  Orphanet J Rare Dis       Date:  2014-07-29       Impact factor: 4.123

6.  Medium-chain triglyceride supplementation under a low-carbohydrate formula is a promising therapy for adult-onset type II citrullinemia.

Authors:  Kiyoshi Hayasaka; Chikahiko Numakura; Kentaro Toyota; Satoru Kakizaki; Hisayoshi Watanabe; Hiroaki Haga; Hiroshi Takahashi; Yoshimi Takahashi; Mieko Kaneko; Mitsunori Yamakawa; Hiroyuki Nunoi; Takeo Kato; Yoshiyuki Ueno; Masatomo Mori
Journal:  Mol Genet Metab Rep       Date:  2014-01-14

7.  Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests.

Authors:  Li-Yun Wang; Nien-I Chen; Pin-Wen Chen; Shu-Chuan Chiang; Wuh-Liang Hwu; Ni-Chung Lee; Yin-Hsiu Chien
Journal:  BMC Med Genet       Date:  2013-02-10       Impact factor: 2.103

8.  SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China.

Authors:  Yuan-Zong Song; Zhan-Hui Zhang; Wei-Xia Lin; Xin-Jing Zhao; Mei Deng; Yan-Li Ma; Li Guo; Feng-Ping Chen; Xiao-Ling Long; Xiang-Ling He; Yoshihide Sunada; Shun Soneda; Akiko Nakatomi; Sumito Dateki; Lock-Hock Ngu; Keiko Kobayashi; Takeyori Saheki
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

9.  Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance.

Authors:  Han-Shi Zeng; Shu-Tao Zhao; Mei Deng; Zhan-Hui Zhang; Xiang-Ran Cai; Feng-Ping Chen; Yuan-Zong Song
Journal:  Int J Mol Med       Date:  2014-09-10       Impact factor: 4.101

10.  Molecular epidemiologic study of citrin deficiency by screening for four reported pathogenic SLC25A13 variants in the Shaanxi and Guangdong provinces, China.

Authors:  Wei-Xia Lin; Muhammad Rauf Yaqub; Zhan-Hui Zhang; Man Mao; Han-Shi Zeng; Feng-Ping Chen; Wei-Ming Li; Wen-Zhe Cai; Ying-Qiang Li; Zhi-Yong Tan; Wei Sheng; Zhi-Min Li; Xiao-Ling Tao; Yuan-Xia Li; Jun-Ping Zhang; Yao-Bin Han; Yan Li; Wu-Qiong Duan; Bao-Ni Ye; Ya-Rong Li; Yuan-Zong Song
Journal:  Transl Pediatr       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.